Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07623291 · ClinicalTrials.gov registry record · NA
Monitoring Blood Pressure at Home and Pharmacy Telehealth
A NA study, sponsored by University of Alabama at Birmingham.
- Not yet
- Registry status
- NA
- Development phase
- 420
- Enrollment target
NCT07623291 is a NA study that has not yet begun recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 420 participants.
The verdict
NCT07623291, a NA study, has not yet begun recruiting, sponsored by University of Alabama at Birmingham.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 420 participants
- Enrollment target
Study Summary
The overall goal of this project is to determine if measuring blood pressure at home and staying in contact with a team of pharmacists and physicians to manage participants' blood pressure is useful. The study will enroll 400 participants who are seen at the University of Alabama at Birmingham Emergency Department - Transitional Care Clinic and Tampa General Hospital -Transitional Care Clinic. Half of the participants (200 patients) will be asked to measure blood pressure at home, and half of the participants (200 patients) will continue to receive usual care. Participants who measure blood pressure at home will also meet with a pharmacist weekly over the phone to discuss blood pressure readings and have blood pressure medications prescribed if needed. This program will last 6 months.
Interventions
- BEHAVIORAL Remote Blood Pressure Monitoring + Telehealth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 420 participants |
| Start Date | 2027-04-01 |
| Est. Completion | 2031-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07623291
The ClinicalTrials.gov registry entry for NCT07623291 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 420 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Remote Blood Pressure Monitoring + Telehealth is the first listed.
NCT07623291 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07623291 about?
NCT07623291 is a clinical study titled "Monitoring Blood Pressure at Home and Pharmacy Telehealth". The overall goal of this project is to determine if measuring blood pressure at home and staying in contact with a team of pharmacists and physicians to manage participants' blood pressure is useful. The study will enroll 400 participants who are seen at the University of Alabama at Birmingham Emerg...
What is the current status of trial NCT07623291?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 420 participants. The study started on 2027-04-01. Estimated completion is 2031-01.
What interventions are being tested in trial NCT07623291?
The interventions under investigation include: Remote Blood Pressure Monitoring + Telehealth (BEHAVIORAL).
Who is sponsoring clinical trial NCT07623291?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.